Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Cendakimab QW/QW and QW/Q2W regimens were assessed as a single treatment group in the analyses from week 0 to week 24 (cendakimab QW) and as separate treatment groups versus placebo in the analyses from weeks 24 to 48
Understanding contraindications and safety considerations is essential before initiating treatment, as certain medical conditions, medications, and life circumstances may preclude their use or require careful medical supervision
Prioritize restful sleep
However, some patients may experience more severe gastrointestinal side effects with Semaglutide GLP-1 compared to Liraglutide
The results will be visible somewhere between six to eight weeks post-treatment
